Zobrazeno 1 - 10
of 2 457
pro vyhledávání: '"large cell neuroendocrine carcinoma"'
Autor:
Taghreed I. Alshafeiy, Hazwa Karathanathodi Hamza, Reem Al-Mazroui, Badriya Al-Qassabi, Suad Al-Aghbari
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 55, Iss 1, Pp 1-6 (2024)
Abstract Background Primary breast carcinoma is far more common than breast metastases. Common breast metastases usually come from lymphoma, leukemia, melanoma, and ovarian cancers. Breast metastases from neuroendocrine carcinomas are considered an e
Externí odkaz:
https://doaj.org/article/1016fc01205f4da1a358e7e8a5fbca59
Publikováno v:
Journal of Mid-Life Health, Vol 15, Iss 3, Pp 206-210 (2024)
We report the case of a 60-year-old female who presented with postmenopausal bleeding after she underwent investigations followed by a total abdominal hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy. A diagnosis of low-gr
Externí odkaz:
https://doaj.org/article/4320a74a3a4e43748159e9010424f6fb
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1042-1049 (2024)
Introduction: Large cell neuroendocrine carcinoma (LCNEC) and atypical carcinoid (AC) tumor are two distinct types of pulmonary neuroendocrine tumors (NETs) that are considered genetically unrelated. AC is categorized as a well-differentiated NET, wh
Externí odkaz:
https://doaj.org/article/b4ba723775a647a2b4407d964c01113a
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 8, Pp 622-628 (2024)
Large cell neuroendocrine carcinoma (LCNEC) of lung is a rare neuroendocrine carcinoma subtype with difficulty in early diagnosis and poor prognosis which is treated with standard strategies of small cell lung cancer and non-small cell lung cancer. I
Externí odkaz:
https://doaj.org/article/d8504fb9208440fcb89c0495a066f321
Autor:
Masamitsu Naka, Atsushi Inaba, Hana Miyasaka, Keisuke Suzue, Junichi Ishigaki, Hideki Shibuya, Kei Hara, Nobuya Ohishi, Yusuke Sugiyama, Yasushi Shiio, Ryosuke Tajiri, Yukiko Kishida, Tasuku Ishihara, Akihiro Yugeta
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-6 (2024)
Abstract Background Recent studies have suggested that N-methyl-D-aspartate (NMDA) receptors are involved in the cell proliferation in several tumors. However, there have been no reports demonstrating the expression of NR1 subunit of the NMDA recepto
Externí odkaz:
https://doaj.org/article/dbe3335df68b42afa4c9677c8814e9be
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundDriver mutations in tyrosine kinases, such as the anaplastic lymphoma kinase (ALK) mutation, are known to play a critical role in the pathogenesis of non-small cell lung cancer (NSCLC) but are rarely observed in large cell neuroendocrine ca
Externí odkaz:
https://doaj.org/article/85ad66f21b23474488dfdaa25480fc80
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTImmune checkpoint inhibitors (ICIs) have emerged as a promising therapeutic option for large cell neuroendocrine carcinoma (LCNEC). However, various studies have suggested a potential risk of hyperprogressive disease (HPD) in patients receivi
Externí odkaz:
https://doaj.org/article/4bdbddadbc0142e580911cf85e32913c
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Combined large cell neuroendocrine carcinoma (CLCNEC) is a rare neuroendocrine carcinoma, accounting for approximately 10% of large cell neuroendocrine carcinoma (LCNEC). Mainly composed of coexisting adenocarcinoma components, with strong invasivene
Externí odkaz:
https://doaj.org/article/52c72d394cc14737bb315068dab193d0
Autor:
Shetal A. Patel, MD, PhD, Young Whang, MD, PhD, Chaely Medley, NP, Kevin Chen, PharmD, Jasmine Jordan, BS, Dante Bortone, PhD, Benjamin Vincent, MD, PhD, Jared Weiss, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 10, Pp 100712- (2024)
A 20-year-old man with metastatic large cell neuroendocrine carcinoma of the lung was treated with the delta-like ligand 3–targeting bispecific T cell engager, tarlatamab. Treatment was complicated by transient cytokine release syndrome but resulte
Externí odkaz:
https://doaj.org/article/8000f77d3fd64147a7f544962cd9ad9f
Publikováno v:
The Clinical Respiratory Journal, Vol 18, Iss 9, Pp n/a-n/a (2024)
ABSTRACT This study reports a significant clinical outcome following the use of bronchoscopic interventional therapy combined with pembrolizumab for treating pulmonary large cell neuroendocrine carcinoma (LCNEC), showcasing a novel approach in managi
Externí odkaz:
https://doaj.org/article/ec8f563119c4400e8be5fb5981fcb3e0